Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 180

1.

Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial.

Mehlum MH, Liestøl K, Wyller TB, Hua TA, Rostrup M, Berge E.

Blood Press. 2019 Apr;28(2):77-83. doi: 10.1080/08037051.2018.1524707. Epub 2019 Jan 6.

PMID:
30614275
2.

Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure.

Farag SM, Rabea HM, Mahmoud HB.

High Blood Press Cardiovasc Prev. 2018 Dec;25(4):407-413. doi: 10.1007/s40292-018-0286-8. Epub 2018 Nov 3.

PMID:
30390203
3.

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.

Ahn Y, Kim Y, Chang K, Kim W, Rhee MY, Cha KS, Hyon MS, Shim CY, Lee SY, Kim DI, Kim SW, Lim SW, Han KR, Jo SH, Lee NH, Kwan J, Ahn T.

Medicine (Baltimore). 2018 Sep;97(37):e12329. doi: 10.1097/MD.0000000000012329.

4.

Effects of hydrochlorothiazide and amlodipine on single oral dose pharmacokinetics of valsartan in healthy Korean subjects: Population model-based approach.

Ngo L, Cho HY, Lee YB.

Eur J Pharm Sci. 2018 Jun 15;118:154-164. doi: 10.1016/j.ejps.2018.03.031. Epub 2018 Mar 29.

PMID:
29604332
5.

The effects of angiotensin receptor neprilysin inhibition by sacubitril/valsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients.

Stinkens R, van der Kolk BW, Jordan J, Jax T, Engeli S, Heise T, Jocken JW, May M, Schindler C, Havekes B, Schaper N, Albrecht D, Kaiser S, Hartmann N, Letzkus M, Langenickel TH, Goossens GH, Blaak EE.

Sci Rep. 2018 Mar 2;8(1):3933. doi: 10.1038/s41598-018-22194-z.

6.

Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension.

Engeli S, Stinkens R, Heise T, May M, Goossens GH, Blaak EE, Havekes B, Jax T, Albrecht D, Pal P, Tegtbur U, Haufe S, Langenickel TH, Jordan J.

Hypertension. 2018 Jan;71(1):70-77. doi: 10.1161/HYPERTENSIONAHA.117.10224. Epub 2017 Nov 27.

7.

Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.

Fujiwara T, Hoshide S, Yano Y, Kanegae H, Kario K.

J Clin Hypertens (Greenwich). 2017 Dec;19(12):1319-1326. doi: 10.1111/jch.13128. Epub 2017 Nov 5.

8.

Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension.

Ishak J, Rael M, Punzi H, Gradman A, Anderson LM, Patel M, Ali S, Ferguson W, Neutel J.

J Clin Hypertens (Greenwich). 2018 Jan;20(1):143-149. doi: 10.1111/jch.13132. Epub 2017 Nov 5.

9.

Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study.

Kim HJ, Han SJ, Kim DJ, Jang HC, Lim S, Choi SH, Kim YH, Shin DH, Kim SH, Kim TH, Ahn YB, Ko SH, Kim NH, Seo JA, Kim HY, Lee KW.

Korean J Intern Med. 2017 May;32(3):497-504. doi: 10.3904/kjim.2015.404. Epub 2016 Dec 30.

10.

Effects of Amlodipine and Valsartan on Blood Pressure Variability and Pulse Wave Velocity in Hypertensive Patients.

Shi R, Liu K, Shi D, Liu Q, Chen X.

Am J Med Sci. 2017 Jan;353(1):6-11. doi: 10.1016/j.amjms.2016.10.005. Epub 2016 Oct 27.

PMID:
28104105
11.

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.

Williams B, Cockcroft JR, Kario K, Zappe DH, Brunel PC, Wang Q, Guo W.

Hypertension. 2017 Mar;69(3):411-420. doi: 10.1161/HYPERTENSIONAHA.116.08556. Epub 2017 Jan 16.

PMID:
28093466
12.

Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolled with amlodipine monotherapy.

Wang JG, Yukisada K, Sibulo A Jr, Hafeez K, Jia Y, Zhang J.

J Hypertens. 2017 Apr;35(4):877-885. doi: 10.1097/HJH.0000000000001219.

PMID:
28030431
13.

Comparison of valsartan and amlodipine on ambulatory blood pressure variability in hypertensive patients.

Eguchi K, Imaizumi Y, Kaihara T, Hoshide S, Kario K.

Clin Exp Hypertens. 2016;38(8):721-724. doi: 10.1080/10641963.2016.1200609. Epub 2016 Dec 12.

PMID:
27936949
14.

Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension.

Supasyndh O, Sun N, Kario K, Hafeez K, Zhang J.

Hypertens Res. 2017 May;40(5):472-476. doi: 10.1038/hr.2016.151. Epub 2016 Nov 17.

PMID:
27853163
15.

Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol.

Hsiao HL, Langenickel TH, Greeley M, Roberts J, Zhou W, Pal P, Rebello S, Rajman I, Sunkara G.

Clin Pharmacol Drug Dev. 2015 Nov;4(6):407-17. doi: 10.1002/cpdd.183. Epub 2015 May 6.

PMID:
27137712
16.

The Effects of Valsartan and Amlodipine on the Levels of Irisin, Adropin, and Perilipin.

Çelik HT, Akkaya N, Erdamar H, Gok S, Kazanci F, Demircelik B, Cakmak M, Yigitoglu R.

Clin Lab. 2015;61(12):1889-95.

PMID:
26882812
17.

Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.

Aksnes TA, Kjeldsen SE, Rostrup M, Holzhauer B, Hua TA, Julius S.

Blood Press. 2016 Aug;25(4):235-40. doi: 10.3109/08037051.2015.1134071. Epub 2016 Jan 25.

PMID:
26808585
18.

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.

Kjeldsen SE, Berge E, Bangalore S, Messerli FH, Mancia G, Holzhauer B, Hua TA, Zappe D, Zanchetti A, Weber MA, Julius S.

Blood Press. 2016;25(2):83-92. doi: 10.3109/08037051.2015.1106750. Epub 2015 Oct 29.

PMID:
26511535
19.

Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).

Motozato K, Miura S, Shiga Y, Kusumoto T, Adachi S, Inoue T, Fujisawa K, Saku K.

Clin Exp Hypertens. 2016;38(1):45-50. doi: 10.3109/10641963.2015.1060982. Epub 2015 Aug 13.

PMID:
26268636
20.

Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight: Subanalysis of China Status II.

Ge B, Peng W, Zhang Y, Wen Y, Liu C, Guo X.

J Cardiovasc Pharmacol. 2015 Nov;66(5):497-503. doi: 10.1097/FJC.0000000000000301.

Supplemental Content

Loading ...
Support Center